Jeb Keiper is the Chief Financial Officer & Chief Business Officer of Nimbus. Prior to joining Nimbus, Jeb was VP of Business Development for GlaxoSmithKline (GSK) Oncology and a member of the Oncology Executive team, and responsible for defining and executing the business development strategy for GSK Oncology, including in-licensing transactions, acquisitions, strategic alliances, academic research relationships, alliance management and competitive intelligence. Alongside these responsibilities, Jeb was also named to lead the GSK-Novartis integration of the commercial oncology business valued at $16B. Prior to GSK, Jeb worked in business development at TransForm Pharmaceuticals, as well as for McKinsey. He began his career at Pfizer as a chemist. He received four degrees from the Massachusetts Institute of Technology (MIT): one degree in Chemistry, two degrees in Chemical Engineering and an M.B.A. from the MIT Sloan School of Management.